Related Experiment Video
Updated: May 15, 2026
Generation of Discriminative Human Monoclonal Antibodies from Rare Antigen-specific B Cells Circulating in Blood
Published on: February 6, 2018
Generation of an antibody toolbox to characterize hERG
Georg J Hausammann1, Thomas Heitkamp, Hugues Matile
1Department of Biochemistry, University of Zurich, 8057 Zurich, Switzerland.
Insights
Researchers developed 12 monoclonal antibodies for the human ether-a-go-go related gene (hERG) potassium channel. These tools enable faster screening of expression and purification conditions for this challenging protein.
Area of Science:
- Biochemistry
- Molecular Biology
- Cardiology
Background:
- The human ether-a-go-go related gene (hERG) potassium channel is crucial for cardiac repolarization.
- hERG dysfunction, due to mutations or drugs, can cause lethal arrhythmias like long QT syndrome.
- Efficient purification of recombinant hERG protein is vital for structural and drug-binding studies.
Purpose of the Study:
- To develop novel tools for the efficient expression, solubilization, and purification of the hERG channel.
- To generate monoclonal antibodies for hERG detection and characterization.
- To facilitate the screening of conditions for hERG protein purification.
Main Methods:
- Generation of 12 monoclonal antibodies against hERG.
- Application of antibodies in Western blot, immunoprecipitation, and immunostaining.
- Development of a sandwich ELISA for hERG quantification.
- Use of a Fab fragment in fluorescence size exclusion chromatography to determine hERG oligomeric state.
Main Results:
- Established 12 monoclonal antibodies with validated applications in various immunological techniques.
- Developed a sensitive sandwich ELISA for relative hERG quantification across different expression systems.
- Determined the oligomeric state of solubilized hERG using fluorescence size exclusion chromatography with a Fab fragment.
- Demonstrated the utility of these tools for rapid screening of hERG purification strategies.
Conclusions:
- The developed monoclonal antibodies and ELISA provide essential tools for advancing hERG research.
- These reagents significantly accelerate the optimization of expression, solubilization, and purification protocols for hERG.
- The findings facilitate structural and biochemical investigations of hERG function and drug interactions.
- Improved methods for hERG protein handling are critical for understanding and treating cardiac channelopathies.
Abstract:
The human ether-a-go-go related gene (hERG) potassium channel plays a major role in the repolarization of the cardiac action potential. Inhibition of the hERG function by mutations or a wide variety of pharmaceutical compounds cause long QT syndrome and lead to potentially lethal arrhythmias. For detailed insights into the structural and biochemical background of hERG function and drug binding, the purification of recombinant protein is essential. Because the hERG channel is a challenging protein to purify, fast and easy techniques to evaluate different expression, solubilization and purification conditions are of primary importance. Here, we describe the generation of a set of 12 monoclonal antibodies against hERG. Beside their suitability in western blot, immunoprecipitation and immunostaining, these antibodies were used to establish a sandwich ELISA for the detection and relative quantification of hERG in different expression systems. Furthermore, a Fab fragment was used in fluorescence size exclusion chromatography to determine the oligomeric state of hERG after solubilization. These new tools can be used for a fast and efficient screening of expression, solubilization and purification conditions.
